Human Hookworm Vaccine Initiative Designs Rapid Deployment Strategy for Developing World
Oct 30, 2009
No Comments »
[Note: This case study was originally published in 2009. Download a PDF or read the case study here.]
A global public-private partnership is in the final stages of a product development and technology transfer program that intends to deliver the world’s first safe, affordable and effective hookworm vaccine to a neglected population — an estimated 3.2 billion men, women and children who live in impoverished rural areas of sub-Saharan African, Southeast Asia, India and the tropical regions of the Americas and are at risk for hookworm infection.
Lessons Learned:
- Strong but flexible program management that coordinates activities, timelines and budgets across continents is critical to achieving success.
- Technical challenges can be overcome with a flexible strategy that allows for collaborative approaches by the program’s partners.
- Functional working relationships with oversight agencies and continued open communication can help partners meet important project milestones.